Align Technology | ALGN - 税前利润

股票价格
179.75
每天变化
-1.11 -0.61%
每月一次
-4.41%
每年
5.74%
Q1 预测
167.98


金融业
股票价格
USD
资产
USD 6.23B
现金及等价物
USD 1B
销售成本
USD 363.97M
流动资产
USD 2.62B
流动负债
USD 1.92B
债务
USD 121.27M
EBIT
USD 224.71M
EBITDA
USD 183.84M
员工
20.95K
EPS每股收益
USD 3.29
股本和储备
USD 3.96B
销售毛利
USD 683.59M
债务利息支出
USD 2M
利息收入
USD 3.25M
贷款资金
USD 0
市值
USD 13.36B
净收入
USD 135.76M
营业费用
USD 822.85M
营业利润
USD 224.71M
普通股股本
USD 71.75M
PE价格收益
19.74
税前利润
USD 176.6M
销售收入
USD 1.05B
销售和管理费用
USD 441.68M
股票
USD 228.16M
贸易债权人
USD 121.45M
应收帐款人
USD 1.1B


税前利润 更改 日
3M USD 759M 390M 2025-12
Align Technology USD 176.6M 81.86M 2025-12
Becton, Dickinson and Co. USD 393M 117M 2025-12
Bruker USD -72.6M 73.1M 2025-09
Cardinal Health USD 598M 214M 2025-09
Charles River Laboratories USD 170.03M 98.62M 2025-09
Cooper Companies USD 116.8M 137.4M 2025-09
CVS Health USD 1.35B 4.84B 2025-12
Danaher USD 1.08B 421M 2025-09
Dentsply International USD -230M 77M 2025-09
Dexcom USD 300M 58.9M 2025-09
Henry Schein USD 137M 16M 2025-09
Idexx Laboratories USD 306.98M 37.79M 2025-12
Insulet USD 140.2M 17.4M 2025-12
Integra LifeSciences USD -6.82M 524.13M 2025-09
IQVIA Holdings USD 6.16B 5.84B 2025-09
Masimo USD 74.9M 19.5M 2025-09
McKesson USD 1.4B 344M 2025-09
Mettler Toledo International USD 269.24M 20.58M 2025-09
Revvity USD 55.68M 115.97M 2025-09
Solventum Corp USD 511M 149M 2025-09
Stryker USD 1.03B 13M 2025-09
Teleflex USD -438.58M 573.82M 2025-09
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Veeva Systems USD 436.85M 14.82M 2025-09
Waters USD 170.12M 7.57M 2025-09
Zimmer Biomet Holdings USD 418.7M 194.1M 2025-09
Zoetis USD 887M 15M 2025-09